{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:15:58Z","timestamp":1762956958790,"version":"3.37.3"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Patients with inflammatory bowel disease (IBD) are at a high risk of developing invasive pneumococcal infection both before and after they are diagnosed. The Advisory Committee on Immunization Practices now endorses use of 2 new pneumococcal conjugate vaccines, PCV15 (Vaxneuvance) and PCV20 (Prevnar 20), for patients who have never received a pneumococcal conjugate vaccine or those with unknown vaccination history. Previous studies have shown that pneumococcal vaccination can decrease the risk of developing severe pneumococcal disease; therefore, it is important that patients with IBD receive pneumococcal vaccination. This report aims to inform clinicians who care for patients with IBD about the changes in immunization practices, as it pertains to pneumococcal vaccination and provides appropriate direction on administering vaccination series.<\/jats:p>","DOI":"10.1093\/ibd\/izac150","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T17:31:25Z","timestamp":1657733485000},"page":"661-664","source":"Crossref","is-referenced-by-count":4,"title":["New Pneumococcal Vaccines for Prevention of Invasive Pneumococcal Disease in Adult Patients With Inflammatory Bowel Disease"],"prefix":"10.1093","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9056-3397","authenticated-orcid":false,"given":"Sheena","family":"Crosby","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Mayo Clinic , Jacksonville, FL , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J","family":"Schuh","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Mayo Clinic , Jacksonville, FL , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Becker","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Mayo Clinic , Rochester, MN , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Ivanov","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Mayo Clinic , Scottsdale, AZ , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1960-6611","authenticated-orcid":false,"given":"Freddy","family":"Caldera","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, University of Wisconsin School of Medicine and Public Health , Milwaukee, WI , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6371-2441","authenticated-orcid":false,"given":"Francis A","family":"Farraye","sequence":"additional","affiliation":[{"name":"Inflammatory Bowel Disease Center, Division of Gastroenterology and Hepatology, Mayo Clinic , Jacksonville, FL , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,7,13]]},"reference":[{"issue":"11","key":"2023040316441566000_","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/ajg.2015.284","article-title":"Inflammatory bowel disease patients are at increased risk of invasive pneumococcal disease: a nationwide Danish cohort study 1977-2013","volume":"110","author":"Kants\u00f8","year":"2015","journal-title":"Am J Gastroenterol."},{"issue":"2","key":"2023040316441566000_","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ajg.2012.406","article-title":"Increased risk of pneumonia among patients with inflammatory bowel disease","volume":"108","author":"Long","year":"2013","journal-title":"Am J Gastroenterol."},{"issue":"8","key":"2023040316441566000_","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/ecco-jcc\/jjab017","article-title":"Gaidos JKJ. Effectiveness of conjugate and polysaccharide pneumococcal vaccines for prevention of severe pneumococcal disease among inflammatory bowel disease patients","volume":"15","author":"Love","year":"2021","journal-title":"J Crohns Colitis"},{"issue":"24","key":"2023040316441566000_","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1001\/jama.2021.22119","article-title":"Two new pneumococcal vaccines-Prevnar 20 and Vaxneuvance","volume":"326","year":"2021","journal-title":"JAMA"},{"issue":"18","key":"2023040316441566000_","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1016\/j.vaccine.2011.02.088","article-title":"Healthcare utilization and cost of pneumococcal disease in the United States","volume":"29","author":"Huang","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"2023040316441566000_","first-page":"462","article-title":"Risk of infection and types of infection among elderly patients with inflammatory bowel disease: a retrospective database analysis","volume":"26","author":"Khan","year":"2020","journal-title":"Inflamm Bowel Dis."},{"issue":"12","key":"2023040316441566000_","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1093\/ibd\/izz093","article-title":"Vaccine-preventable diseases in hospitalized patients with inflammatory bowel disease: a nationwide cohort analysis","volume":"25","author":"Vinsard","year":"2019","journal-title":"Inflamm Bowel Dis."},{"key":"2023040316441566000_","doi-asserted-by":"crossref","DOI":"10.1097\/MCG.0000000000001635","article-title":"The burden of vaccine-preventable diseases in patients with inflammatory bowel disease","author":"Kr\u00f6ner","year":"2022","journal-title":"J Clin Gastroenterol."},{"issue":"2","key":"2023040316441566000_","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.crohns.2012.02.015","article-title":"Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases","volume":"7","author":"Ananthakrishnan","year":"2013","journal-title":"J Crohns Colitis"},{"issue":"4","key":"2023040316441566000_","doi-asserted-by":"crossref","first-page":"109","DOI":"10.15585\/mmwr.mm7104a1","article-title":"Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. adults: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022","volume":"71","author":"Kobayashi","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep."},{"year":"2022","author":"Centers for Disease Control and Prevention","key":"2023040316441566000_"},{"issue":"9","key":"2023040316441566000_","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.14309\/ajg.0000000000000713","article-title":"Vaccination in patients with inflammatory bowel disease","volume":"115","author":"Caldera","year":"2020","journal-title":"Am J Gastroenterol."},{"issue":"4","key":"2023040316441566000_","first-page":"595","article-title":"Immunogenicity of the currently recommended pneumococcal vaccination schedule in patients with inflammatory bowel disease","volume":"70","author":"van Aalst","year":"2020","journal-title":"Clin Infect Dis."},{"issue":"4","key":"2023040316441566000_","first-page":"605","article-title":"Timing is everything: pneumococcal immunization in inflammatory bowel disease","volume":"70","author":"Grijalva","year":"2020","journal-title":"Clin Infect Dis."},{"issue":"1","key":"2023040316441566000_","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/ibd\/izaa055","article-title":"Optimizing immunization strategies in patients with IBD","volume":"27","author":"Caldera","year":"2021","journal-title":"Inflamm Bowel Dis."},{"year":"2022","author":"General best practice guidelines for immunization","key":"2023040316441566000_"},{"issue":"8","key":"2023040316441566000_","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1572-0241.2006.00646.x","article-title":"Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses","volume":"101","author":"Melmed","year":"2006","journal-title":"Am J Gastroenterol."},{"issue":"9","key":"2023040316441566000_","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1007\/s10620-020-06631-6","article-title":"Accuracy of self-reported vaccination status in a cohort of patients with inflammatory bowel disease","volume":"66","author":"Smith","year":"2021","journal-title":"Dig Dis Sci."},{"key":"2023040316441566000_","first-page":"1","article-title":"Safety of immunizations for the adult patient with inflammatory bowel disease-a systematic review and meta-analysis","author":"Desalermos","year":"2021","journal-title":"Inflamm Bowel Dis."},{"volume-title":"Product Information: PREVNAR 20 intramuscular injection, pneumoccoccal 20-valent conjugate vaccine intramuscular injection","year":"2021","key":"2023040316441566000_"},{"volume-title":"Product Information: VAXNEUVANCE intramuscular suspension, pneumococcal 15-valent conjugate vaccine intramuscular suspension","year":"2021","key":"2023040316441566000_"},{"author":"Cardinal Health","key":"2023040316441566000_"}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izac150\/44856699\/izac150.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/29\/4\/661\/49733184\/izac150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/29\/4\/661\/49733184\/izac150.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T14:46:08Z","timestamp":1700837168000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/29\/4\/661\/6643251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,13]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,7,13]]},"published-print":{"date-parts":[[2023,4,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izac150","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"type":"print","value":"1078-0998"},{"type":"electronic","value":"1536-4844"}],"subject":[],"published-other":{"date-parts":[[2023,4,1]]},"published":{"date-parts":[[2022,7,13]]}}}